​

Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Fennec Pharmaceuticals Ownership Summary


Fennec Pharmaceuticals is owned by 52.04% institutional investors, 14.09% insiders, and 33.88% retail investors. Rosalind advisors is the largest institutional shareholder, holding 9.28% of FENC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.20% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFennec Pharmaceuticals52.04%14.09%33.88%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rosalind advisors3.19M9.28%$34.27M
Sonic gp2.41M8.80%$15.21M
Aigh capital management2.50M7.24%$26.62M
Blackrock funding, inc. /de2.03M5.89%$21.66M
Solas capital management1.89M5.50%$20.31M
Blackrock1.19M4.39%$7.25M
Vanguard group1.07M3.83%$8.22M
Awm investment company1.16M3.36%$12.36M
Vanguard capital management839.31K2.43%$8.94M
Prospect capital advisors497.80K1.45%$5.35M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sonic gp2.41M33.54%$15.21M
Rosalind advisors3.19M12.73%$34.27M
Solas capital management1.89M10.88%$20.31M
Lion point capital, lp112.43K5.78%$1.21M
Aigh capital management2.50M2.68%$26.62M
Prospect capital advisors497.80K2.43%$5.35M
Potomac capital management224.50K1.85%$2.39M
Awm investment company1.16M1.19%$12.36M
Essex investment management318.77K0.50%$3.39M
1492 capital management49.95K0.18%$531.91K

Top Buyers

HolderShares% AssetsChange
Prospect capital advisors497.80K2.43%497.80K
Essex investment management318.77K0.50%318.77K
Tang capital management334.59K0.12%314.07K
Blackrock funding, inc. /de2.03M0.00%306.33K
Rosalind advisors3.19M12.73%279.80K

Top Sellers

HolderShares% AssetsChange
Southpoint capital advisors lp---2.74M
Solas capital management1.89M10.88%-592.83K
Apis capital advisors---204.00K
Harbert fund advisors---177.81K
Jane street group57.10K0.00%-176.77K

New Positions

HolderShares% AssetsChangeValue
Prospect capital advisors497.80K2.43%497.80K$5.35M
Essex investment management318.77K0.50%318.77K$3.39M
Sierra summit advisors127.55K0.16%127.55K$1.36M
Legato capital management98.33K0.09%98.33K$1.05M
Wellington management group llp84.55K0.00%84.55K$908.89K

Sold Out

HolderChange
Sbi securities-1.00
Nelson, van denburg & campbell wealth management group-3.00
Capital performance advisors llp-5.00
Wealth preservation advisors-5.00
Mai capital management-18.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202612010.09%17,975,5529.69%522.31%59-19.18%3383.33%
Jun 30, 202610717.58%16,386,8401.15%472.14%7230.91%17-5.56%
Mar 31, 202687-8.42%16,173,7894.09%561.82%5110.87%18-25.00%
Dec 31, 202541-50.60%7,252,139-47.69%261.04%16-57.89%9-62.50%
Sep 30, 202537-48.61%3,501,549-73.61%120.55%10-73.68%12-45.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF882.05K3.20%5.84K
Vanguard Morn Total Stk Mkt Idx Investor815.19K2.35%-
Vanguard Total Stock Mkt Idx Inv815.19K2.35%-
Vanguard MStar Total Stk Mkt Idx Invest815.19K2.32%-
iShares Russell 2000 ETF736.89K2.10%-
Fidelity Small Cap Index318.80K0.91%2.33K
iShares Russell 2000 Growth ETF275.82K0.79%-1.04K
Russell 2000 Index Non-Lendable Fund192.08K0.55%47.28K
Russell 2000 Equity Index Fund B192.08K0.55%47.28K
iShares Russell 2000 Value ETF184.14K0.53%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 15, 2026Brughera Marco Maria-Sell$159.96K
Sep 01, 2026Raykov Rosty Former DirectorSell$121.10K
Aug 31, 2026Sayad Pierre Sargis Chief Medical OfficerSell$146.16K
Aug 27, 2026Andrade Robert CHIEF FINANCIAL OFFICERSell$883.50K
Aug 03, 2026Raykov Rosty Former DirectorSell$95.80K

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3-6
2026 Q2-4
2026 Q1-3
2025 Q4-11

FENC Ownership FAQ


Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 52.04%, followed by 14.09% insiders and 33.87% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 181.71%, which Fennec Pharmaceuticals falls below.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Rosalind advisors (3.19M shares, 9.28%), Sonic gp (2.41M shares, 8.80%), and Aigh capital management (2.5M shares, 7.24%). Together, they hold 25.32% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 33.54% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 15.21M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Fennec Pharmaceuticals shares, with 3.20% of its total shares outstanding invested in 882.05K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools